FDA Issues 510(k) Clearance for Emerging Enterprise Imaging Platform
Offering rapid loading and viewing access for CT, MRI, ultrasound, PET imaging and mammograms, the ImageGrid® StreamVue platform can be integrated into existing PACS environments at hospitals and imaging centers.
The Food and Drug Administration (FDA) has cleared ImageGrid® StreamVue, a next-generation viewing platform that reportedly facilitates rapid access to a variety of imaging, regardless of a radiologist’s location.
Through a combination of proprietary image streaming technology and a focus on imaging data needed for immediate review,
In addition to the platform’s utility for hospitals, imaging centers and remote reading settings, Candelis emphasized that ImageGrid® StreamVue can be integrated into existing DICOM-compliant PACS environments.
“For too long, health-care organizations have had to choose between legacy viewers that slow radiologists down and costly enterprise platforms that can be difficult to justify. StreamVue eliminates this tradeoff by allowing providers to keep their existing PACS, while providing fast and responsive access to diagnostic images whether they are on-site or working remotely. With many deployment options, StreamVue provides healthcare organizations with a practical way to modernize their enterprise imaging with minimal disruption,” noted Robert Van Uitert, the vice president of marketing and products at Candelis.
Related to this article
